Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T21029 |
Norfluoxetine Hydrochloride
Norfluoxetine HCl,去甲氟西汀 |
Others | Others |
Norfluoxetine Hydrochloride (Norfluoxetine HCl) 是氟西汀的活性代谢物。氟西汀是一种抗抑郁药。 | |||
T26174 |
SAK3
SAK 3,SAK-3 |
Calcium Channel; AChR | Membrane transporter/Ion channel; Metabolism; Neuroscience |
SAK3 是一种新型的 nAChR 活性调节剂,可增强 T 型电压门控 Ca2+ 通道 (T-VGCC) 的活性,对 Cav3.1 和 Cav3.3 T 型 Ca2+ 通道电流均有增强作用。SAK3 对人神经母细胞瘤 SH-SY5Y 细胞中东莨菪碱诱导的胆碱能功能障碍有神经保护作用。SAK3 可用于研究记忆缺陷和阿尔茨海默病。 | |||
T12076 |
ML218 hydrochloride
|
Others | Others |
ML218 hydrochloride is a selective and orally active T-type Ca2+ channels (Cav3.1, Cav3.2, Cav3.3) inhibitor (Cav3.2 and Cav3.3 with IC50s of 310 nM and 270 nM , respectively). | |||
T12076L |
ML218
|
Calcium Channel | Membrane transporter/Ion channel; Metabolism |
ML218 是一种具有口服活性、选择性、高效性且可穿透血脑屏障的 T 型 Ca2+ 通道抑制剂(Cav3.2 和 Cav3.3 的 IC50 分别为 310 nM 和 270 nM)。ML218 可抑制丘脑下核(STN)神经元的突发性活动。 | |||
T64203 | T-Type calcium channel inhibitor 2 | ||
T-Type calcium channel inhibitor 2 (compound 6g) 是一种 T 型钙通道的有效抑制剂,能够作用于 Cav3.1 (α1G) (IC50: 31.0 μM)、Cav3.2 (α1H) (IC50: 83.1 μM)、Cav3.3 (α1I) (α1H) (IC50: 69.3 μM)。T-Type calcium channel inhibitor 2 对 A549、HCT-116 细胞表现出细胞毒性,IC50s 分别为5.0、6.4 μM。 | |||
T36070 |
(±)5(6)-EET
|
||
5(6)-EET is a fully racemic version of the enantiomeric forms biosynthesized from arachidonic acid by cytochrome P450 enzymes. In solution, 5(6)-EET degrades into 5,6-DiHET and 5(6)-δ-lactone, which can be converted to 5(6)-DiHET and quantified by GC-MS. In neuroendocrine cells, such as the anterior pituitary and pancreatic islets, 5(6)-EET has been implicated in the mobilization of calcium and hormone secretion. 5(6)-EET is an inhibitor of T-type voltage-gated calcium channels (Cav3) that inhib... |